ARCHIVES

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

November 18, 2011

Funding Opportunities (8-page issue).

May 23, 2003

Rosemond Asks Ban On High Tar, Nicotine Cigarettes

November 28, 1975